Our Collaborators
Research partnerships that drive innovation across medicinal chemistry, microbiology, cancer research, and environmental science
The Kumar Research Group collaborates with leading researchers across Australia and internationally. Our partnerships span antimicrobial development, cancer drug discovery, environmental remediation, and computational drug design.
Emeritus Prof. David StC Black
UNSW Sydney
Emeritus Professor of Organic Chemistry at UNSW and former Secretary General of IUPAC. Longstanding collaborator in heterocyclic chemistry and medicinal chemistry.
View Profile
Prof. Mark Willcox
School of Optometry and Vision Science, UNSW
Medical microbiologist working on antimicrobial coatings and infections related to medical devices. Leads the Willcox Research Group.
View Profile LinkedIn
Prof. Peter Lewis
University of Newcastle
Researcher working on bacterial transcription and antimicrobial discovery.
View Profile LinkedIn
Prof. Belamy-Bin Cheung
Children's Cancer Institute, UNSW
Collaborates on neuroblastoma research and MYCN-targeted therapeutics.
View Profile
Prof. Glenn Marshall
Children's Cancer Institute / UNSW
Collaborates on childhood cancer research and neuroblastoma therapeutics.
View Profile
Prof. Kyle Hoehn
School of Biotechnology & Biomolecular Sciences, UNSW
Collaborates on metabolic and systems biology research.
View Profile
Prof. Denis O'Carroll
UNSW Sydney
Collaborates on environmental chemistry and PFAS remediation research.
View Profile
Prof. Michael Manefield
UNSW Sydney
Collaborates on environmental microbiology and PFAS remediation.
View Profile
Prof. Serkan Saydam
UNSW Sydney
Collaborates on mining engineering and geotechnical research.
View Profile
Prof. Bill Walsh
UNSW Sydney
Collaborates on biomedical engineering and materials research.
View Profile
Adjunct Prof. Peter Karuso
School of Biotechnology & Biomolecular Sciences, UNSW
Isolation of bioactive molecules and drugs from natural products.
View Profile
Prof. Levon Khachigian
School of Biomedical Sciences, UNSW
Vascular biology and translational research. Heads the Vascular Biology and Translational Research Laboratory. Research on transcriptional control, novel experimental drugs for cardiovascular disease, cancer, and eye disease.
View Profile
Prof. Graham Kelly
Filamon Ltd
Co-Founder, CEO and Managing Director of Filamon. Career in cancer research, drug development and public company corporate experience. Founded Novogen (Kazia Therapeutics), MEI Pharma, Noxopharm and Nyrada.
View Profile
Prof. William Alexander Donald
School of Chemistry, UNSW
ARC Future Fellow developing analytical and mass spectrometry methodologies for chemistry and biochemistry. Expertise in ion mobility, native mass spectrometry and single-cell analysis.
View Profile
Prof. Cyrille Boyer
School of Chemical Engineering, UNSW
Co-director of Australian Centre for NanoMedicine. Research on photopolymerization, photoredox catalysis, RAFT polymerization, smart nanomaterials and functional polymeric materials for drug delivery.
View Profile
Assoc. Prof. Tushar Kumeria
School of Materials Science & Engineering, UNSW
NHMRC Early Career Fellow. Research on porous materials for drug delivery, tissue engineering scaffolds and photonic crystal-based sensors for biomedical and environmental applications.
View Profile
Assoc. Prof. Pramod Koshy
School of Materials Science & Engineering, UNSW
Co-leader of NEMCAT group. Research on advanced materials for environmental and energy applications, waste transformation into value-added materials, photocatalytic films and bioceramic coatings.
View Profile
Dr Edgar Wong
School of Chemical Engineering, UNSW
ARC Future Fellow and Scientia Fellow. Research on smart antimicrobial polymers, peptide-mimicking anticancer and antiviral macromolecules, and antimicrobial coatings.
View Profile
Dr Rajesh Kuppusamy
UNSW Sydney
Visiting Fellow researching antimicrobial peptides, antivirals and disinfectants.
View Profile
Dr Daniel Wenholz
UNSW / Noxopharm
Director of Pharmaceutical Chemistry at Noxopharm and former UNSW researcher. Collaborates on FLT3 inhibitors and cancer drug discovery.
View Profile LinkedIn
Dr Frances Byrne
School of Biotechnology & Biomolecular Sciences (BABS), UNSW
Research focuses on targeting cancer metabolism using novel small molecules.
View Profile
Dr Renxun Chen
UNSW Sydney
Collaborates on antimicrobial coatings and biomaterials. Former Kumar Group PhD student.
View Profile
Dr. Satyanarayana Gadde
Collaborates on Targeting MYCN with New Scaffolds for Anticancer Discovery.
View Profile LinkedIn